(CWCO) Consolidated Water - Overview
Exchange: NASDAQ •
Country: Cayman Islands •
Currency: USD •
Type: Common Stock •
ISIN: KYG237731073
Stock: Potable Water, Desalination Plants, Reverse Osmosis Systems, Water Treatment
Total Rating 58
Risk 93
Buy Signal 0.26
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.72% |
| Yield on Cost 5y | 4.36% |
| Yield CAGR 5y | 10.12% |
| Payout Consistency | 94.3% |
| Payout Ratio | 55.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 30.9% |
| Relative Tail Risk | -7.93% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.16 |
| Alpha | 32.27 |
| Character TTM | |
|---|---|
| Beta | 0.308 |
| Beta Downside | 0.171 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.23% |
| CAGR/Max DD | 0.98 |
Description: CWCO Consolidated Water December 27, 2025
Consolidated Water Co. Ltd. (NASDAQ:CWCO) operates a vertically integrated water business across the Cayman Islands, the Bahamas, the United States, and the British Virgin Islands, delivering potable water, wastewater treatment, and water-reuse services through its Retail, Bulk, Services, and Manufacturing segments.
Key performance indicators from the most recent filing show 2023 revenue of roughly $166 million, an operating margin of about 12 %, and a net debt-to-EBITDA ratio near 2.0×, indicating modest leverage for a utility-type asset base.
Primary growth drivers include rising water scarcity in the Caribbean, sustained tourism-related water demand, and U.S. infrastructure spending that fuels demand for outsourced water-treatment and desalination projects; the company’s reverse-osmosis technology positions it to capture a larger share of these expanding markets.
For a deeper dive into CWCO’s valuation metrics and peer comparison, you might explore the detailed analysis on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 16.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA -3.35 > 1.0 |
| NWC/Revenue: 108.3% < 20% (prev 84.29%; Δ 24.05% < -1%) |
| CFO/TA 0.14 > 3% & CFO 35.2m > Net Income 16.9m |
| Net Debt (-120.3m) to EBITDA (24.5m): -4.92 < 3 |
| Current Ratio: 6.03 > 1.5 & < 3 |
| Outstanding Shares: last quarter (16.0m) vs 12m ago 0.34% < -2% |
| Gross Margin: 35.60% > 18% (prev 0.36%; Δ 3524 % > 0.5%) |
| Asset Turnover: 52.80% > 50% (prev 66.62%; Δ -13.83% > 0%) |
| Interest Coverage Ratio: 3332 > 6 (EBITDA TTM 24.5m / Interest Expense TTM 5721 ) |
Altman Z'' 9.85
| A: 0.55 (Total Current Assets 169.9m - Total Current Liabilities 28.2m) / Total Assets 257.2m |
| B: 0.45 (Retained Earnings 116.1m / Total Assets 257.2m) |
| C: 0.08 (EBIT TTM 19.1m / Avg Total Assets 247.8m) |
| D: 4.05 (Book Value of Equity 125.6m / Total Liabilities 31.0m) |
| Altman-Z'' Score: 9.85 = AAA |
Beneish M -3.22
| DSRI: 1.11 (Receivables 35.7m/39.2m, Revenue 130.8m/158.8m) |
| GMI: 1.00 (GM 35.60% / 35.53%) |
| AQI: 0.87 (AQ_t 0.09 / AQ_t-1 0.11) |
| SGI: 0.82 (Revenue 130.8m / 158.8m) |
| TATA: -0.07 (NI 16.9m - CFO 35.2m) / TA 257.2m) |
| Beneish M-Score: -3.22 (Cap -4..+1) = AA |
What is the price of CWCO shares?
As of February 08, 2026, the stock is trading at USD 37.03 with a total of 92,192 shares traded.
Over the past week, the price has changed by -2.24%, over one month by +3.90%, over three months by +8.83% and over the past year by +40.14%.
Over the past week, the price has changed by -2.24%, over one month by +3.90%, over three months by +8.83% and over the past year by +40.14%.
Is CWCO a buy, sell or hold?
Consolidated Water has received a consensus analysts rating of 4.50.
Therefore, it is recommended to buy CWCO.
- StrongBuy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CWCO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 43 | 16.1% |
| Analysts Target Price | 43 | 16.1% |
| ValueRay Target Price | 50 | 35% |
CWCO Fundamental Data Overview February 02, 2026
P/E Trailing = 34.7523
P/E Forward = 24.1546
P/S = 4.6126
P/B = 2.7242
P/EG = 2.2449
Revenue TTM = 130.8m USD
EBIT TTM = 19.1m USD
EBITDA TTM = 24.5m USD
Long Term Debt = 34.8k USD (from longTermDebt, last quarter)
Short Term Debt = 729.5k USD (from shortTermDebt, last quarter)
Debt = 3.22m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -120.3m USD (from netDebt column, last quarter)
Enterprise Value = 483.1m USD (603.5m + Debt 3.22m - CCE 123.6m)
Interest Coverage Ratio = 3332 (Ebit TTM 19.1m / Interest Expense TTM 5721 )
EV/FCF = 18.51x (Enterprise Value 483.1m / FCF TTM 26.1m)
FCF Yield = 5.40% (FCF TTM 26.1m / Enterprise Value 483.1m)
FCF Margin = 19.95% (FCF TTM 26.1m / Revenue TTM 130.8m)
Net Margin = 12.90% (Net Income TTM 16.9m / Revenue TTM 130.8m)
Gross Margin = 35.60% ((Revenue TTM 130.8m - Cost of Revenue TTM 84.3m) / Revenue TTM)
Gross Margin QoQ = 36.86% (prev 38.20%)
Tobins Q-Ratio = 1.88 (Enterprise Value 483.1m / Total Assets 257.2m)
Interest Expense / Debt = 0.03% (Interest Expense 901.0 / Debt 3.22m)
Taxrate = 12.58% (827.0k / 6.57m)
NOPAT = 16.7m (EBIT 19.1m * (1 - 12.58%))
Current Ratio = 6.03 (Total Current Assets 169.9m / Total Current Liabilities 28.2m)
Debt / Equity = 0.01 (Debt 3.22m / totalStockholderEquity, last quarter 220.4m)
Debt / EBITDA = -4.92 (Net Debt -120.3m / EBITDA 24.5m)
Debt / FCF = -4.61 (Net Debt -120.3m / FCF TTM 26.1m)
Total Stockholder Equity = 215.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.81% (Net Income 16.9m / Total Assets 257.2m)
RoE = 7.85% (Net Income TTM 16.9m / Total Stockholder Equity 215.1m)
RoCE = 8.86% (EBIT 19.1m / Capital Employed (Equity 215.1m + L.T.Debt 34.8k))
RoIC = 7.74% (NOPAT 16.7m / Invested Capital 215.2m)
WACC = 7.01% (E(603.5m)/V(606.7m) * Re(7.05%) + D(3.22m)/V(606.7m) * Rd(0.03%) * (1-Tc(0.13)))
Discount Rate = 7.05% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 0.93%
[DCF Debug] Terminal Value 84.23% ; FCFF base≈28.5m ; Y1≈34.2m ; Y5≈54.7m
Fair Price DCF = 80.26 (EV 1.16b - Net Debt -120.3m = Equity 1.28b / Shares 15.9m; r=7.01% [WACC]; 5y FCF grow 21.37% → 2.90% )
EPS Correlation: 50.32 | EPS CAGR: 47.09% | SUE: 0.62 | # QB: 0
Revenue Correlation: 57.78 | Revenue CAGR: 22.03% | SUE: 0.38 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.41 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=1.56 | Chg30d=-0.020 | Revisions Net=-2 | Growth EPS=+25.8% | Growth Revenue=+37.7%
P/E Forward = 24.1546
P/S = 4.6126
P/B = 2.7242
P/EG = 2.2449
Revenue TTM = 130.8m USD
EBIT TTM = 19.1m USD
EBITDA TTM = 24.5m USD
Long Term Debt = 34.8k USD (from longTermDebt, last quarter)
Short Term Debt = 729.5k USD (from shortTermDebt, last quarter)
Debt = 3.22m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -120.3m USD (from netDebt column, last quarter)
Enterprise Value = 483.1m USD (603.5m + Debt 3.22m - CCE 123.6m)
Interest Coverage Ratio = 3332 (Ebit TTM 19.1m / Interest Expense TTM 5721 )
EV/FCF = 18.51x (Enterprise Value 483.1m / FCF TTM 26.1m)
FCF Yield = 5.40% (FCF TTM 26.1m / Enterprise Value 483.1m)
FCF Margin = 19.95% (FCF TTM 26.1m / Revenue TTM 130.8m)
Net Margin = 12.90% (Net Income TTM 16.9m / Revenue TTM 130.8m)
Gross Margin = 35.60% ((Revenue TTM 130.8m - Cost of Revenue TTM 84.3m) / Revenue TTM)
Gross Margin QoQ = 36.86% (prev 38.20%)
Tobins Q-Ratio = 1.88 (Enterprise Value 483.1m / Total Assets 257.2m)
Interest Expense / Debt = 0.03% (Interest Expense 901.0 / Debt 3.22m)
Taxrate = 12.58% (827.0k / 6.57m)
NOPAT = 16.7m (EBIT 19.1m * (1 - 12.58%))
Current Ratio = 6.03 (Total Current Assets 169.9m / Total Current Liabilities 28.2m)
Debt / Equity = 0.01 (Debt 3.22m / totalStockholderEquity, last quarter 220.4m)
Debt / EBITDA = -4.92 (Net Debt -120.3m / EBITDA 24.5m)
Debt / FCF = -4.61 (Net Debt -120.3m / FCF TTM 26.1m)
Total Stockholder Equity = 215.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.81% (Net Income 16.9m / Total Assets 257.2m)
RoE = 7.85% (Net Income TTM 16.9m / Total Stockholder Equity 215.1m)
RoCE = 8.86% (EBIT 19.1m / Capital Employed (Equity 215.1m + L.T.Debt 34.8k))
RoIC = 7.74% (NOPAT 16.7m / Invested Capital 215.2m)
WACC = 7.01% (E(603.5m)/V(606.7m) * Re(7.05%) + D(3.22m)/V(606.7m) * Rd(0.03%) * (1-Tc(0.13)))
Discount Rate = 7.05% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 0.93%
[DCF Debug] Terminal Value 84.23% ; FCFF base≈28.5m ; Y1≈34.2m ; Y5≈54.7m
Fair Price DCF = 80.26 (EV 1.16b - Net Debt -120.3m = Equity 1.28b / Shares 15.9m; r=7.01% [WACC]; 5y FCF grow 21.37% → 2.90% )
EPS Correlation: 50.32 | EPS CAGR: 47.09% | SUE: 0.62 | # QB: 0
Revenue Correlation: 57.78 | Revenue CAGR: 22.03% | SUE: 0.38 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.41 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=1.56 | Chg30d=-0.020 | Revisions Net=-2 | Growth EPS=+25.8% | Growth Revenue=+37.7%